Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy-Reference-Cited by-同舟云学术

Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy

Published:2023-07 Issue:4 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Hellwig Kerstin¹^ORCID,Tokic Marianne¹,Thiel Sandra¹,Hemat Spalmai¹,Timmesfeld Nina¹,Ciplea Andrea I.¹,Gold Ralf¹,Langer-Gould Annette M.¹

Affiliation:

1. From the Department of Neurology (K.H., S.T., S.H., A.I.C., R.G.), St. Josef-Hospital—Katholisches Klinikum Bochum, Ruhr University Bochum; Department of Medical Informatics (M.T., N.T.), Biometry and Epidemiology, Ruhr University Bochum, Germany; Department of Neurology (A.M.L.-G.), Los Angeles Medical Center, Southern California Permanente Medical Group.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200110

Reference31 articles.

1. FDA. FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod). Accessed February 20 2022. fda.gov/drugs/drug-safety-and-availability/fda-warns-about-severe-worsening-multiple-sclerosis-after-stopping-medicine-gilenya-fingolimod.

2. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

3. Pregnancy in Multiple Sclerosis

4. Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era

5. Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy;Multiple Sclerosis Journal;2024-09-12

2. Multiple Sklerose: Therapie bei Kinderwunsch und in der Schwangerschaft;Deutsches Ärzteblatt Online;2024-08-09

3. Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy;Clinical and Translational Neuroscience;2024-08-01

4. Pregnancy and reproductive health in women with multiple sclerosis: an update;Current Opinion in Neurology;2024-04-08

5. Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France;Neurology and Therapy;2024-03-15